Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.41 |
| ▸ | PDE4A | P27815 | 1/20 | 0.41 |
| ▸ | SLC6A6 | P31641 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | BLM | P54132 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.36 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL476377 | 0.94 | APP (0.50) | APPLMNAPTGS1PDE4ASLC6A6 | |
| SCHEMBL27026941 | 0.92 | APP (0.48) | APPLMNAPTGS1PDE4ASLC6A6 | |
| Eprodisate SCHEMBL34216 | 0.84 | APP (0.65) | APPLMNAPTGS1PDE4ASLC6A6 | |
| SCHEMBL3913999 | 0.84 | ALDH1A1 (0.46) | LMNACYP2C19ALDH1A1TP53NLRP3 | |
| SCHEMBL13321333 | 0.83 | APP (0.41) | APPLMNAPTGS1PDE4ASLC6A6 | |
| SCHEMBL26323059 | 0.82 | APP (0.50) | APPLMNAPTGS1PDE4ASLC6A6 | |
| SCHEMBL11695951 | 0.81 | LMNA (0.45) | APPLMNAPTGS1PDE4ASLC6A6 | |
| Eprodisate SCHEMBL23795563 | 0.81 | APP (0.61) | APPLMNAPTGS1PDE4ASLC6A6 | |
| Eprodisate SCHEMBL2288862 | 0.81 | APP (0.61) | APPLMNAPTGS1PDE4ASLC6A6 | |
| Eprodisate SCHEMBL2522163 | 0.81 | APP (0.61) | APPLMNAPTGS1PDE4ASLC6A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 129 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2630129-B1 | QUINOXALINE DERIVATES | MERCK PATENT GMBH (DE) | 2016-10-26 | — | — | EP | claimed |
| US-8895559-B2 | Quinoxalines derivatives and pharmaceutical compositions and kits | MERCK PATENT GMBH (DE) | 2014-11-25 | — | — | US | claimed |
| US-20130217670-A1 | QUINOXALINE DERIVATIVES | MERCK PATENT GMBH (DE) | 2013-08-22 | — | — | US | claimed |
| US-11912882-B2 | Ink set | SEIKO EPSON CORPORATION (JP) | 2024-02-27 | — | — | US | disclosed |
| US-20240018376-A1 | AQUEOUS ADDITIVE SOLUTION FOR INK COMPOSITION, AQUEOUS COLORANT SOLUTION FOR INK COMPOSITION, INK COMPOSITION, INK COMPOSITION FOR INK JET RECORDING, AND INK JET RECORDING METHOD | FUJIFILM CORPORATION (JP) | 2024-01-18 | — | — | US | disclosed |
| CN-116265453-A | Compounds as AR inhibitors and uses thereof | 南京圣和药业股份有限公司 | 2023-06-20 | — | — | CN | disclosed |
| US-10016981-B2 | Aqueous ink set for ink jet recording, recording method, and ink jet recording apparatus | SEIKO EPSON CORPORATION (JP) | 2018-07-10 | — | — | US | disclosed |
| US-9944807-B2 | Ink composition and ink set | SEIKO EPSON CORPORATION (JP) | 2018-04-17 | — | — | US | disclosed |
| US-20180001643-A1 | AQUEOUS INK SET FOR INK JET RECORDING, RECORDING METHOD, AND INK JET RECORDING APPARATUS | SEIKO EPSON CORPORATION (JP) | 2018-01-04 | — | — | US | disclosed |
| US-9822268-B2 | Ink composition | SEIKO EPSON CORPORATION (JP) | 2017-11-21 | — | — | US | disclosed |
| US-20170247557-A1 | COMPOUND, INK, INK CARTRIDGE AND INK JET RECORDING METHOD | CANON KABUSHIKI KAISHA (JP) | 2017-08-31 | — | — | US | disclosed |
| US-7241332-B2 | Ink jet yellow ink, ink set, ink jet recording method, ink cartridge, recording unit, and ink jet recording apparatus | CANON KABUSHIKI KAISHA (JP) | 2007-07-10 | — | — | US | disclosed |
| US-7226728-B2 | Photothermographic material | FUJIFILM CORPORATION (JP) | 2007-06-05 | — | — | US | disclosed |
| US-20070120920-A1 | Ink for inkjet, ink set for inkjet, and inkjet recording method | FUJIFILM CORPORATION (JP) | 2007-05-31 | — | — | US | disclosed |
| US-7223453-B2 | Ink jet recording medium and ink jet recording method | FUJIFILM CORPORATION (JP) | 2007-05-29 | — | — | US | disclosed |
| US-7219988-B2 | Water-soluble phthalocyanine compound-containing ink for ink jetting, ink jet recording method and method for improving ozone gas discoloration of colored image material | FUJI PHOTO FILM CO., LTD. (JP) | 2007-05-22 | — | — | US | disclosed |
| US-20070109376-A1 | Ink composition, ink set and recording method | FUJIFILM CORPORATION | 2007-05-17 | — | — | US | disclosed |
| US-20070072136-A1 | Photothermographic material | FUJI PHOTO FILM CO., LTD. | 2007-03-29 | — | — | US | disclosed |
| US-20070015095-A1 | Photothermographic material | FUJI PHOTO FILM CO., LTD. | 2007-01-18 | — | — | US | disclosed |
| US-7157220-B2 | Silver halide photosensitive material and photothermographic material | FUJIFILM CORPORATION (JP) | 2007-01-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170247557-A1 | COMPOUND, INK, INK CARTRIDGE AND INK JET RECORDING METHOD | JAK1, JAK2, ETV6 | APP 4357/4885LMNA 4849/4885PTGS1 2720/4885 |
| US-20130217670-A1 | QUINOXALINE DERIVATIVES | PIK3R5, NQO2, PIK3R1 | APP 1739/4885LMNA 2968/4885PTGS1 124/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.